Ken Griffin acquired 94.3 Thousand Beam Therapeutics shares worth $2.87 Million. That's 0.00% of their equity portfolio (2307th largest holding). The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $8.38 Million, resulting in a loss of 66%.